XRGenomics has significant capacity in the field of personalized medicine, including RNA based diagnostic technologies for geriatric medicine and clinical prognosis. We focus on the development of RNA diagnostics to provide advanced warning for chronic diseases, such dementia and pre-diabetes because measures of RNA capture more clinically useful and actionable information than other types of genomic technology


Management Team

Prof Jamie Timmons PhD – Director and CSO


Jamie founded XRGenomics in 2012 on the back of a decade of OMIC work carried out at the Karolinska Institutet. Trained in biomedical sciences, metabolism and genomics he has spent the last decade raising >£10 million for personalized medicine projects. Jamie also works part-time as a Professor in Precision Medicine, King's College London. 

Mr Gordon Farquhar – COO


Gordon has two decades of experience in management strategy and consulting. A graduate from Strathclyde University, Glasgow, Gordon has worked with major international companies, such as British Airways and Royal Bank of Scotland, solving complex logistic and technology related challenges

Dr Niels Vollaard PhD – Director


Niels qualified with multiple post-graduate degrees in physiology and nutrition. A lead investigator on the EU metapredict study (www.metapredict.eu) Niels is an expert in human physiology and clinical data analysis


Intellectual Property Advisors

Mr Robert Gleave, Patent Attorney


Wallingford, Oxfordshire



Mr Kevin Varney


Varney Barfield and Company

Corunna Road, Warwick, CV34 5HQ


VAT number 139 6153 01

European Union Research PIC number is 949388471